1. Home
  2. KMDA vs ALRS Comparison

KMDA vs ALRS Comparison

Compare KMDA & ALRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • ALRS
  • Stock Information
  • Founded
  • KMDA 1990
  • ALRS 1879
  • Country
  • KMDA Israel
  • ALRS United States
  • Employees
  • KMDA N/A
  • ALRS N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • ALRS Major Banks
  • Sector
  • KMDA Health Care
  • ALRS Finance
  • Exchange
  • KMDA Nasdaq
  • ALRS Nasdaq
  • Market Cap
  • KMDA 399.7M
  • ALRS 468.2M
  • IPO Year
  • KMDA N/A
  • ALRS 2019
  • Fundamental
  • Price
  • KMDA $6.85
  • ALRS $21.35
  • Analyst Decision
  • KMDA Strong Buy
  • ALRS Hold
  • Analyst Count
  • KMDA 3
  • ALRS 5
  • Target Price
  • KMDA $14.67
  • ALRS $23.20
  • AVG Volume (30 Days)
  • KMDA 80.5K
  • ALRS 77.4K
  • Earning Date
  • KMDA 05-14-2025
  • ALRS 07-23-2025
  • Dividend Yield
  • KMDA 2.92%
  • ALRS 3.94%
  • EPS Growth
  • KMDA 31.21
  • ALRS 118.02
  • EPS
  • KMDA 0.28
  • ALRS 1.08
  • Revenue
  • KMDA $167,235,000.00
  • ALRS $224,218,000.00
  • Revenue This Year
  • KMDA $14.51
  • ALRS $40.50
  • Revenue Next Year
  • KMDA $9.31
  • ALRS $3.54
  • P/E Ratio
  • KMDA $23.98
  • ALRS $19.43
  • Revenue Growth
  • KMDA 11.83
  • ALRS 35.73
  • 52 Week Low
  • KMDA $4.74
  • ALRS $15.78
  • 52 Week High
  • KMDA $9.16
  • ALRS $24.41
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 52.85
  • ALRS 59.26
  • Support Level
  • KMDA $6.64
  • ALRS $20.74
  • Resistance Level
  • KMDA $6.99
  • ALRS $21.20
  • Average True Range (ATR)
  • KMDA 0.17
  • ALRS 0.49
  • MACD
  • KMDA -0.02
  • ALRS -0.15
  • Stochastic Oscillator
  • KMDA 58.00
  • ALRS 47.06

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About ALRS Alerus Financial Corporation

Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.

Share on Social Networks: